BioWorld Insider Podcast

One-on-one with medical innovators

Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collective work is changing how we all live. Join us for a new conversation.

Howard Fillit, executive director and chief science officer, Alzheimer’s Drug Discovery Foundation

As dementia cases grow, biomarkers and new therapies key to unlocking treatment

Play

Listen

Duration: 34:00

07-29-2021

Howard Fillit, founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation, shares his insights on the impact of financial investments driving these therapies.

Download transcript

Download episode

Karen-Carey,-analyst,-BioWorld-podcast-7-8-.png

As biopharma deals keep pace, M&A volumes languish

Play

Listen

Duration: 14:00

07-08-2021

Biopharma deal-making activity, a closely watched marker of industry health, was alive and well in the second quarter. BioWorld Senior Analyst Karen Carey sifts through the numbers.

Download transcript

Download episode